AstraZeneca picks Catalent for packaging potential COVID-19 vaccine

AstraZeneca Plc has struck a deal with Catalent Inc for packaging its potential COVID-19 vaccine, as the British drugmaker prepares to meet its global target of making two billion doses of the vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.